Ask AI
HRF-10071 Phase IIa
HRF-10071: Phase IIa Dose-Ranging, Monotherapy Trial of a Next-generation HIV-1 Maturation Inhibitor in People With HIV Infection

Released: July 18, 2025

Expiration: January 17, 2026

Activity

Progress
1
Course Completed
Activity Information

Released: July 18, 2025

Expiration: January 17, 2026